Conditional Long-Term Survival after Autologous Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma-Reference-Cited by-同舟云学术

Conditional Long-Term Survival after Autologous Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma

Published:2019-12 Issue:12 Volume:25 Page:2522-2526
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

El-Asmar Jessica,Rybicki Lisa,Bolwell Brian J.,Kharfan-Dabaja Mohamed A.,Dean Robert,Hamilton Betty K.,Hanna Rabi,Jagadeesh Deepa,Kalaycio Matt,Pohlman Brad,Sobecks Ronald,Hill Brian T.,Majhail Navneet S.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference17 articles.

1. Hematopoietic cell transplantation for diffuse large B-cell follicular lymphoma: current controversies and advances;Epperla;Hematol Oncol Stem Cell Ther,2017

2. Clinical and treatment-related features determining the risk of late relapse in patients with diffuse large B-cell lymphoma;Modvig;Br J Haematol,2017

3. A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma;Smeland;Br J Haematol,2016

4. Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age;McCarthy;Biol Blood Marrow Transplant,2013

5. Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large B-cell lymphoma;Myers;Cancer,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transplant-ineligible but chimeric antigen receptor T-cells eligible: a real and relevant population;European Journal of Cancer;2022-11

2. Trends in Late Mortality and Life Expectancy After Autologous Blood or Marrow Transplantation Over Three Decades: A BMTSS Report;Journal of Clinical Oncology;2022-06-20

3. A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients;Cancer Medicine;2022-04-22